Stericycle (NASDAQ:SRCL) PT Lowered to $55.00

Stericycle (NASDAQ:SRCL) had its price objective lowered by investment analysts at Robert W. Baird from $62.00 to $55.00 in a report released on Friday, Benzinga reports. The brokerage presently has a “neutral” rating on the business services provider’s stock. Robert W. Baird’s target price points to a potential upside of 18.76% from the stock’s current price.

SRCL has been the subject of a number of other research reports. Stifel Nicolaus increased their price objective on shares of Stericycle from $70.00 to $75.00 and gave the company a “buy” rating in a research note on Thursday, February 29th. Truist Financial increased their price objective on shares of Stericycle from $50.00 to $57.00 and gave the company a “hold” rating in a research note on Thursday, February 29th. StockNews.com cut shares of Stericycle from a “buy” rating to a “hold” rating in a research note on Tuesday, April 2nd. Wells Fargo & Company upped their target price on shares of Stericycle from $40.00 to $48.00 and gave the stock an “underweight” rating in a report on Friday, March 1st. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and issued a $69.00 target price on shares of Stericycle in a report on Thursday, March 7th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $60.80.

Stericycle Price Performance

NASDAQ:SRCL opened at $46.31 on Friday. Stericycle has a one year low of $37.78 and a one year high of $57.06. The stock has a market cap of $4.30 billion, a P/E ratio of -210.50, a PEG ratio of 2.50 and a beta of 1.09. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.11 and a quick ratio of 0.94. The company has a fifty day moving average price of $51.35 and a 200 day moving average price of $48.20.

Stericycle (NASDAQ:SRCL) last announced its quarterly earnings data on Thursday, April 25th. The business services provider reported $0.57 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.54 by $0.03. Stericycle had a negative net margin of 0.74% and a positive return on equity of 7.31%. The company had revenue of $664.90 million during the quarter, compared to analysts’ expectations of $676.42 million. During the same quarter in the prior year, the company posted $0.49 EPS. The business’s revenue was down 2.8% on a year-over-year basis. Analysts anticipate that Stericycle will post 2.32 earnings per share for the current year.

Institutional Investors Weigh In On Stericycle

Several large investors have recently made changes to their positions in SRCL. Capital Research Global Investors grew its holdings in shares of Stericycle by 13.4% in the 4th quarter. Capital Research Global Investors now owns 5,987,937 shares of the business services provider’s stock worth $296,762,000 after purchasing an additional 705,586 shares during the last quarter. Sei Investments Co. grew its holdings in Stericycle by 35.5% during the 4th quarter. Sei Investments Co. now owns 1,061,369 shares of the business services provider’s stock worth $52,601,000 after acquiring an additional 277,896 shares during the last quarter. Ariel Investments LLC grew its holdings in Stericycle by 5.7% during the 3rd quarter. Ariel Investments LLC now owns 4,328,036 shares of the business services provider’s stock worth $193,506,000 after acquiring an additional 233,612 shares during the last quarter. Heartland Advisors Inc. grew its holdings in Stericycle by 55.5% during the 4th quarter. Heartland Advisors Inc. now owns 583,545 shares of the business services provider’s stock worth $29,733,000 after acquiring an additional 208,256 shares during the last quarter. Finally, Dimensional Fund Advisors LP grew its holdings in Stericycle by 10.8% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,971,719 shares of the business services provider’s stock worth $97,720,000 after acquiring an additional 192,045 shares during the last quarter. Institutional investors own 98.82% of the company’s stock.

About Stericycle

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.